MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/bph.70348

Медицинская библиотека · British journal of pharmacology · 2026

Inhibition of GRK2 mitigates cisplatin-induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis.

Duan Fei, Ni Lei, Wang Qianlei, Peng Jie, Wang Xueru, Wang Yin, Hu Shuoshuo, Kuai Jiajie, Jiang Xiao, Wang Qingtong, Xu Bingfa, Wei Wei, Wang Chun

СтатьяПеревод в очереди

Аннотация

BACKGROUND AND PURPOSE: Cisplatin nephrotoxicity involves oxidative stress, with NADPH oxidase 4 (NOX4) in renal tubular epithelial cells (RTECs) as a potential source of key reactive oxygen species (ROS). Although G protein-coupled receptor kinase 2 (GRK2) contributes to tissue injury, its regulatory role in cisplatin nephrotoxicity via NOX4 remains undefined. We have investigated the underlying mechanisms of GRK2 in cisplatin-induced acute and chronic nephrotoxicity.

EXPERIMENTAL APPROACH: Hemizygous Grk2 knockout mice and homozygous Grk2 knockout RTECs were utilised. The GRK2-NOX4 interaction was investigated by co-immunoprecipitation or glutathione S-transferase pull-down. Kinase assays and ubiquitination experiments were performed to investigate the regulatory effect of GRK2 on the phosphorylation and ubiquitination of NOX4. Acute, sub-chronic and chronic cisplatin models, as well as syngeneic tumour models, evaluated the renoprotection afforded by the GRK2 inhibitor CP-25 and its impact on chemotherapy efficacy.

KEY

RESULTS

Grk2 deficiency attenuated cisplatin-induced nephrotoxicity in vivo and reduced RTEC death and epithelial-mesenchymal transition (EMT) in vitro. Grk2 knockout or knockdown downregulated NOX4 expression, which repressed NOX4-mediated ROS release and oxidative stress, preventing cisplatin-induced RTEC death and EMT. GRK2 promoted NOX4 phosphorylation and suppressed ubiquitin-mediated degradation, thereby increasing NOX4 stability and ROS production. CP-25 effectively ameliorated cisplatin-induced nephrotoxicity, suppressed oxidative stress, and reduced renal apoptosis and EMT without compromising its anticancer efficacy. These protective effects also were observed in vitro.

CONCLUSION AND IMPLICATIONS: GRK2 plays a crucial role in cisplatin-induced nephrotoxicity by modulating NOX4, suggesting that targeting GRK2 is an effective renoprotective strategy for cisplatin-based cancer therapy.

Для цитирования: Duan Fei, Ni Lei, Wang Qianlei, Peng Jie, Wang Xueru, Wang Yin, Hu Shuoshuo, Kuai Jiajie, Jiang Xiao, Wang Qingtong, Xu Bingfa, Wei Wei, Wang Chun. Inhibition of GRK2 mitigates cisplatin-induced acute and chronic nephrotoxicity by targeting the NADPH oxidase 4/oxidative stress axis.. British journal of pharmacology. 2026. DOI: 10.1111/bph.70348.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.